About
Real Seq Biosciences develops RNA fragmentomics technology for discovering novel RNA biomarkers using their proprietary RiboMarker® platform, enabling advanced diagnostic applications in oncology, infectious disease, and other fields.
Explore Real Seq Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.